生物製藥 CMO 和 CRO 市場（按材料、服務、產品和地區）

Biopharmaceutical CMO and CRO Market, By Source, By Service, and By Product, and By Geography

出版日期: 2025年05月21日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

生物製藥 CMO 和 CRO 市場規模預計在 2025 年達到 406 億美元，預計到 2032 年將達到 606.5 億美元，2025 年至 2032 年的複合年成長率為 5.9%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	406億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	5.90%	2032年價值預測	606.5億美元

生物製藥CMO（受託製造廠商）是一家以合約為基礎的公司，為生物製藥領域的其他公司提供服務，從藥品製造服務到包裝；而CRO（委外研發機構）是一家以委託研究服務的形式為生物製藥公司提供支援的公司。

市場動態：

慢性病的增加、藥物發現和開發的增加、對生技藥品和生物學名藥的需求增加、外包趨勢的上升、研發投資的增加以及生物製藥行業的快速成長是預計推動全球生物製藥 CMO 和 CRO 市場成長的關鍵因素。

例如，2023年2月，Lunaphor與SironaDx宣布達成策略合作，SironaDx將成為第一個提供Lunaphor旗艦產品COMET空間生物學平台即服務的美國合約研究組織（CRO）。 COMET是對SironaDx委外研發機構組合的補充，旨在滿足跨學科研究人員和生物製藥團隊的需求。 COMET服務於跨學科、涵蓋研究和藥物開發各個階段的廣泛研究應用。

本研究的主要特點

本報告對全球生物製藥 CMO 和 CRO 市場進行了詳細分析，並以 2024 年為基準年，提供了 2025 年至 2032 年預測期內的市場規模和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了全球生物製藥 CMO 和 CRO 市場中主要企業的概況。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、高階市場策略、市場擴張和行銷策略做出明智的決策。
全球生物製藥 CMO 和 CRO 市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球生物製藥 CMO 和 CRO 市場所使用的各種策略矩陣來簡化決策。

Allphase Clinical Research
AlcheraBio
Alcami
Akos Urgent Care
Agilent
AGC Biologics
Affinity Life Sciences, Inc.
Actimus Bio
ACI Clinical
Accumedix, Inc.
Absorption Systems
A10 Clinical Solutions
Albuquerque Clinical Trials（ACT）
Ajinomoto Bio-Pharma Services
Advanced Clinical Services LLC
ACM Global Laboratories
Accelerated Enrollment Solutions
AbbVie Contract Manufacturing
Advanced BioScience Laboratories
Advanced Clinical Research Institute
Alliance for Clinical Trials in Oncology

第9章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI5933

Biopharmaceutical CMO and CRO Market is estimated to be valued at USD 40.6 Bn in 2025 and is expected to reach USD 60.65 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 40.6 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.90%	2032 Value Projection:	USD 60.65 Bn

Biopharmaceutical CMO (Contract Manufacturing Organization) is a company that serves other companies in the biopharmaceutical sector on a contract basis to offer services ranging from drug manufacturing services to packaging. While, Contract Research Organization (CRO) is a company that provides support to biopharmaceutical companies in the form of research services outsourced on a contract basis.

Market Dynamics:

Rise in burden of chronic diseases, increasing drug discovery and development, increasing demand for biologics and biosimilars, growing trend of outsourcing, increasing investment in research and development and the rapid growth of the biopharmaceutical industry are major factors expected to augment the growth of the global biopharmaceutical CMO and CRO market.

For instance, in February 2023, Lunaphore and Sirona Dx announced a strategic collaboration in which Sirona Dx will become the first US-based Contract Research Organization (CRO) to offer Lunaphore's flagship COMET spatial biology platform as a service. A COMET will complement Sirona Dx's portfolio of research service offerings to meet the needs of researchers and biopharma teams across various disciplines. COMET has a wide range of research applications across multiple disciplines and all stages of research and drug development.

Key features of the study:

This report provides in-depth analysis of the global biopharmaceutical CMO and CRO market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global biopharmaceutical CMO and CRO market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include AlcheraBio, Alcami, Akos Urgent Care, Agilent, AGC Biologics, Affinity Life Sciences, Inc., Actimus Bio, ACI Clinical, Accumedix, Inc., Allphase Clinical Research, Absorption Systems, A10 Clinical Solutions, Albuquerque Clinical Trials (ACT), Ajinomoto Bio-Pharma Services, Advanced Clinical Services LLC, ACM Global Laboratories, Accelerated Enrollment Solutions, AbbVie Contract Manufacturing, Advanced BioScience Laboratories, Advanced Clinical Research Institute, and Alliance for Clinical Trials in Oncology, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global biopharmaceutical CMO and CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biopharmaceutical CMO and CRO market.

Detailed Segmentation:

Global Biopharmaceutical CMO and CRO Market, By Source:
- Mammalian
- Non-mammalian
Global Biopharmaceutical CMO and CRO Market, By Service:
- Contract Manufacturing
- Contract Research
Global Biopharmaceutical CMO and CRO Market, By Product:
- Biologics
- Biosimilars
Global Biopharmaceutical CMO and CRO Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- Allphase Clinical Research
- AlcheraBio
- Alcami
- Akos Urgent Care
- Agilent
- AGC Biologics
- Affinity Life Sciences, Inc.
- Actimus Bio
- ACI Clinical
- Accumedix, Inc.
- Absorption Systems
- A10 Clinical Solutions
- Albuquerque Clinical Trials (ACT)
- Ajinomoto Bio-Pharma Services
- Advanced Clinical Services LLC
- ACM Global Laboratories
- Accelerated Enrollment Solutions
- AbbVie Contract Manufacturing
- Advanced BioScience Laboratories
- Advanced Clinical Research Institute
- Alliance for Clinical Trials in Oncology

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Contract Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Contract Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Biopharmaceutical CMO and CRO Market, By Product, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Biosimilars
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Biopharmaceutical CMO and CRO Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Allphase Clinical Research
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AlcheraBio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alcami
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Akos Urgent Care
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AGC Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Affinity Life Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Actimus Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ACI Clinical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Accumedix, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Absorption Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
A10 Clinical Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Albuquerque Clinical Trials (ACT)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ajinomoto Bio-Pharma Services
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Advanced Clinical Services LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ACM Global Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Accelerated Enrollment Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie Contract Manufacturing
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Advanced BioScience Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Advanced Clinical Research Institute
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alliance for Clinical Trials in Oncology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views